Mei Han

Dr. Mei Han

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 February 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
ECEnbo Cai
Enbo Cai
XSXingzhuo Song
Xingzhuo Song
MHMei Han
Mei Han
LYLimin Yang
Limin Yang
YZYan Zhao
Yan Zhao
STShumei Tu
Shumei Tu
Arctigenin (ARG) is a functional active component that has important physiological and pharmacological activities. The anti-tumour and anti-inflammatory activities of ARG show good potential for application and development, but this material has the defect of low water solubility. In this experiment, the valine derivative of ARG (ARG-V) was designed and synthesized to overcome this disadvantage. The ARG amino acid, EDCI and DMAP were raw materials in the addition reaction, with a molar ratio of 1:2:2:0.5. The yield of ARG-V was up to 80%. ARG-V has strong anti-tumour activity in vivo and in vitro. The inhibitory rate of ARG-V was 69.2%, with less damage to the immune organs and different degrees of increased serum cytotoxicity. Moreover, the pharmacokinetics of ARG following oral administration and ARG-V following oral administration in rats were also studied. The Cmax and AUC values of ARG-V showed significant differences compared to ARG. The relative bioavailabilities of three doses of ARG-V compared to ARG were 664.7%, 741.5% and 812.9%. These pharmacokinetic results may be useful for further studies of the bioactive mechanism of ARG and provide a theoretical basic for clinical use.

1 May 2020 in Chemical and Pharmaceutical Bulletin
Verified
Journal Article
Open access
PDF file
SWSi-Qi Wang
Si-Qi Wang
XYXiao Yang
Xiao Yang
YZYong-Gang Zhang
Yong-Gang Zhang
ECEn-Bo Cai
En-Bo Cai
XZXiao-Man Zheng
Xiao-Man Zheng
LYLimin Yang
Limin Yang
Ginseng (G) and Prepared Rehmannia Root (PRR) are commonly used in traditional Chinese medicine for blood supplementation. This study aimed to study G and PRR with different compatibility ratios changes in chemical composition and inhibition of cyclophosphamide-induced myelosuppression. HPLC was used to determine the chemical constituents of 13 ginsenosides, 5-Hydroxymethylfurfural (5-HMF) and verbascoside in different proportions of G-PRR. Balb/C mice were injected intraperitoneally with cyclophosphamide (CTX) to induce bone marrow suppression.The effects of different proportions of G-PRR on peripheral blood, bone marrow nucleated cells, thymus and spleen index of myelosuppressed mice were analyzed. The results showed that the compatibility of G and PRR can promote the dissolution of ginsenosides, and the content of conventional ginsenosides decreased, and the content of rare ginsenosides increased. Different proportions of G-PRR increased the number of peripheral blood and bone marrow nucleated cells in cyclophosphamide-induced bone marrow suppression mice (p<0.01), increased thymus index (p<0.01), decreased spleen index (p<0.01). Different proportions of G-PRR can improve the myelosuppression induced by cyclophosphamide in mice, and the combined effect of G-PRR is better than the single decoction of G and PRR. Among them, G-PRR2:3 and G-PRR1:2 were better than the other groups. These results indicate that different proportion of G-PRR can improve bone marrow suppression, and the combined decoction of G-PRR is better than the separate Decoction in improving bone marrow suppression. This improvement may be related to the changes of the substance basis and active ingredients of G-PRR.